Contract Research & Services
Contract Research

Contract Research

RXi Pharmaceuticals enters into research collaboration with Iovance Biotherapeutics RXi Pharmaceuticals has partnered with Iovance Biotherapeutics to evaluate its sd-rxRNA therapeutic compounds with the latter’s autologous cell therapy based on tumor-infiltrating lymphocytes (TILs) for the use in the treatment of cancer.
Contract Research & Services > Contract Research > News
NetVation DL Medicine enters into research collaboration with Pfizer Chinese biotechnology company NetVation DL Medicine, which is focused on the discovery and development of novel drug candidates, has entered into a two-year research collaboration with Pfizer.
Contract Research & Services > Contract Research > News FDA puts Bellicum's cancer drug trials on clinical hold By PBR Staff Writer
The US Food and Drug Administration (FDA) has placed clinical hold on Bellicum Pharmaceuticals' trials evaluating its cell therapy BPX-501 (genetically modified T cells) after reports of three cases of brain disease.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight